UBS analyst Kevin Caliendo reiterated a Buy rating and $13.00 price target on AdaptHealth (NASDAQ: AHCO).The analyst comments "AHCO's fundamentals ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE